1.89
price down icon1.05%   -0.02
after-market Handel nachbörslich: 1.91 0.02 +1.06%
loading

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.61%
0.113
0.107 0.11 0.064 0.023
Operating Expenses
23.73%
3.967
5.201 5.66 6.224 7.109
Benefits Costs and Expenses
23.73%
3.967
5.201 5.66 11.78 7.109
Costs And Expenses
23.73%
3.967
5.201 5.66 6.224 7.109
Operating Income/Loss
24.34%
-3.854
-5.094 -5.55 -6.16 -7.086
Income/Loss From Continuing Operations Before Tax
24.34%
-3.854
-5.094 -5.55 -11.71 -7.086
Income/Loss From Continuing Operations After Tax
24.34%
-3.854
-5.094 -5.55 -6.16 -7.086
Net Income/Loss
24.34%
-3.854
-5.094 -5.55 -6.16 -7.086
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.16%
4.5377
4.1192 83.48 7.8564 47.32
Diluted Average Shares
10.16%
4.5377
4.1192 83.48 7.8564 47.32
Basic Earnings Per Share
31.45%
-0.85
-1.24 -0.07 -0.04 -0.15
Diluted Earnings Per Share
31.45%
-0.85
-1.24 -0.07 -0.04 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):